it was mentioned you do work for a competitor. if not, what is your motive to keep providing negative commentary on SAS? seems odd to me.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025